ClinConnect ClinConnect Logo
Search / Trial NCT06183723

Optimizing Care for Challenging People Living With HIV

Launched by KAOHSIUNG MEDICAL UNIVERSITY CHUNG-HO MEMORIAL HOSPITAL · Dec 14, 2023

Trial Information

Current as of July 22, 2025

Enrolling by invitation

Keywords

Hiv Adherence Social Media Platform

ClinConnect Summary

This is an intervention strategy for HIV-infected individuals based on their viral load measurements and medication adherence rates, measured by the proportion of days covered (PDC) for the past 365 days. A specific PDC threshold identifies individuals with less than 90% viral suppression at under 200 copies/mL. An intervention approach integrating social and behavioral models with electronic health (eHealth) technology is implemented for cases with a PDC below this threshold. The intervention aims to enhance the patient's adherence to their medication regimen. The effectiveness of this int...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. PLWH with adherence below the specific proportion of days covered (PDC), which is defined as the specific level that corresponds to 90% at viral suppression (\< 200 copies/mL).
  • Exclusion Criteria:
  • 1. Under 18 years of age.
  • 2. Illiterate.
  • 3. Non-consenting individuals.
  • 4. Less than 365 days from the initial use of antiretroviral drugs to the assessment for inclusion in the study.
  • 5. Inability to obtain complete medication records for the 365 days prior to inclusion.
  • 6. Lack of a smart phone.
  • 7. No willingness to return for follow-up at the participating hospital.

About Kaohsiung Medical University Chung Ho Memorial Hospital

Kaohsiung Medical University Chung-Ho Memorial Hospital is a leading healthcare institution in Taiwan, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor, the hospital leverages its extensive expertise in various medical disciplines, state-of-the-art facilities, and a multidisciplinary team of professionals to conduct rigorous clinical studies. Committed to ethical standards and patient safety, the hospital collaborates with academic institutions and industry partners to facilitate groundbreaking research that contributes to the global medical community and enhances treatment options for diverse patient populations.

Locations

Kaohsiung City, , Taiwan

Patients applied

0 patients applied

Trial Officials

Chun-Yuan Lee, M.D.

Principal Investigator

Kaohsiung Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported